AP NEWS

Global Stem Cell Banking Market to 2023 - Market is Dominated by Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), and Cryo-Cell International - ResearchAndMarkets.com

September 25, 2018

DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application - Global Forecasts to 2023 ” report has been added to ResearchAndMarkets.com’s offering.

The global stem cell banking market is projected to reach USD 9.30 billion by 2023 from 6.28 billion in 2018, at a CAGR of 8.2%

Stem cell banking market growth is mainly driven by the factors such as public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing number of stem cell-based research. However, the high operational costs associated with stem cell banking and stringent regulatory frameworks are expected to limit the growth of the stem cell banking market during the forecast period.

Based on source, the stem cell banking market is segmented into placental, bone marrow-derived, adipose tissue-derived, human embryo-derived, dental pulp, and other stem cell sources. The placental stem cells segment is projected to grow at the highest rate during the forecast period; owing to the global rise in the number of placental and cord banks (especially in the US and Europe) coupled with growing public awareness about the therapeutic potential of stem cells.

G eographically, the stem cell banking market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to register the highest CAGR during the forecast period due to the growing number of stored units with public & private stem cell banks; supportive regulatory framework for stem cell collection, processing, and preservation across major Asian countries; increased collaborations & partnerships between stem cell banking service providers to expand their networks across emerging countries; rising public awareness about the clinical benefits of stem cell therapies; and ongoing expansion & modernization of healthcare infrastructure.

The global stem cell banking market is an expanding industry segment with a growing number of global and local service providers. As of 2017, the global stem cell banking market was dominated by Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), and Cryo-Cell International (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Stem Cell Banking Market, By Source

7 Stem Cell Banking Market, By Service Type

8 Stem Cell Banking Market, By Application

9 Stem Cell Banking Market, By Region

10 Competitive Landscape

11 Company Profiles

Cord Blood Registry Systems Cordlife Cryo-Cell International Cryo-Save AG (A Subsidiary of Esperite N.V) CryoHoldco Global Cord Blood LifeCell International Smart Cells International StemCyte ViaCord (A Subsidiary of Perkinelmer) Vita34 For more information about this report visit https://www.researchandmarkets.com/research/3dnpmd/global_stem_cell?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180925005987/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Stem Cells

KEYWORD:

INDUSTRY KEYWORD: STEM CELLS HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/25/2018 12:53 PM/DISC: 09/25/2018 12:53 PM

http://www.businesswire.com/news/home/20180925005987/en

AP RADIO
Update hourly